Catalyst Wire Dossier Catalyst Wire Dossier

Brompheniramine maleate, pseudoephedrine hydrochloride and dextromethorphan hydrobromide

brompheniramine maleate; pseudoephedrine hydrochloride; dextromethorphan hydrobromide · Padagis US LLC
Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for Brompheniramine maleate, pseudoephedrine hydrochloride and dextromethorphan hydrobromide, covering 2014-07-15 to 2023-05-08. Get the full timeline:

Most recent: FDA Approved: BROMPHENIRAMINE MALEATE, PSEUDOEPHEDRINE HYDROCHLORIDE AND DEXTROMETHORPHAN HYDROBROMIDE — Supplemental Application (PAI Holdings, LLC dba PAI Pharma)

See pricing